Benjamin Wolozin

Benjamin Wolozin is a Professor at the Boston University Chobanian & Avedisian School of Medicine in the Department of Pharmacology, with an adjunct position in Neurology. He specializes in neurodegenerative diseases, particularly Alzheimer's, Parkinson's, and ALS.

• MD/PhD, Albert Einstein College of Medicine
• Past Associate Professor at Loyola University Medical Center (1996-2004)
• Current affiliations: Alzheimer's Disease Center, Boston University Graduate Program for Neuroscience

His research investigates RNA binding proteins (RBPs), stress granules, and liquid-liquid phase separation in neurodegenerative disease. Key projects include the role of TIA1 and HNRNPA2B1 in tauopathy, m6A RNA methylation in Alzheimer's pathology, and development of 3D iPS-neuron/astrocyte assembloids to model dementia. His lab has identified disease-linked circRNA changes and explores nanobodies targeting stress granule components.

Recent awards include the Donald B. Lindsley Prize (Society for Neuroscience) and A. E. Bennett Award. He serves on NIH CDIN study sections and editorial boards for Journal of Biological Chemistry and Neurodegenerative Diseases. Grants include multiple NIH R01 and U01 awards for AD/tauopathy research.